Letram (Levetiracetam)

Levetiracetam is a widely used anticonvulsant (antiepileptic) medication prescribed to control a variety of seizure types. It works by binding to the SV2A protein in the brain, helping regulate abnormal electrical activity and reducing seizure frequency. This makes Levetiracetam effective for managing partial‑onset seizures, myoclonic seizures, and primary generalized tonic‑clonic seizures in adults and children. Levetiracetam is suitable for both monotherapy and adjunctive therapy, depending on the patient’s condition. It has a favorable drug‑interaction profile, predictable pharmacokinetics, and straightforward dosing, making it a preferred choice for many clinicians. This category includes a wide range of dosage forms such as immediate‑release tablets, extended‑release tablets, oral solutions, tablets for suspension, and injectable formulations, allowing for personalized treatment across age groups and clinical scenarios. All Levetiracetam products offered in this category are sourced from trusted pharmaceutical manufacturers, ensuring potency, consistency, and safety for everyday seizure management.